健康元 (600380)
Joincare Pharmaceutical Group Industry Co., Ltd.
K-Line Chart
No K-line data available
Company NameJiankangyuan Pharmaceutical Group Co., Ltd.
Listing Date2001-06-08
Issue Price24.8RMB
Registered Capital182945.338610k RMB
Legal RepresentativeZhu Baoguo
Registered AddressJiankangyuan Pharmaceutical Group Building, No. 17 Langshan Road, North District, High-tech Park, Nanshan District, Shenzhen City, Guangdong Province
IndustryChemical Pharmaceuticals
Main BusinessThe company is a comprehensive pharmaceutical enterprise, primarily engaged in the research, development, production, and operation of traditional Chinese medicine, health products, and Western medicine.
Company ProfileJiankangyuan Pharmaceutical Group Co., Ltd. was formerly known as Shenzhen Taitai Health Food Co., Ltd., establishing its leading position in the health product industry with the "Taitai Oral Liquid". In 1995, it strategically transformed into the pharmaceutical industry and was renamed Shenzhen Taitai Pharmaceutical Co., Ltd. In 1997, it acquired Shenzhen Haibin Pharmaceutical Co., Ltd., successfully transitioning from a health product enterprise to a pharmaceutical enterprise. In 1999, it completed its shareholding system reform and was renamed Shenzhen Taitai Pharmaceutical Co., Ltd. (Joint Stock Company). Jiankangyuan Pharmaceutical Group subsequently acquired high-quality pharmaceutical enterprises such as Health Pharmaceutical (China) Co., Ltd. and Livzon Pharmaceutical Group Inc. In 2003, it was renamed Jiankangyuan Pharmaceutical Group Co., Ltd.
Stock Details
1. Key Indicators
- Total Shares(W): 182945.34
- Circulating A-Shares(W): 182945.34
- Earnings Per Share(RMB): 0.6000
- Net Assets Per Share(RMB): 8.1262
- Operating Revenue(W RMB): 1147780.69
- Total Profit(W RMB): 285273.56
- **Net Profit Attributable to Parent(W RMB) **: 109121.41
- Net Profit Growth Rate(%): -1.83
- Weighted Return on Equity(%): 7.4600
- Operating Cash Flow Per Share(RMB): 1.6410
- Undistributed Profit Per Share(RMB): 6.1297
- Capital Reserve Per Share(RMB): 0.5604
2. Main Business
The main business covers:
- Chinese patent medicine
- Oral liquid
- Tablets
- Capsules
- Granules
- Hormone tablets
3. Company Basic Information
- Company Name: Joincare Pharmaceutical Group Industry Co., Ltd.
- Listing Date: 2001-06-08
- Industry: Pharmaceutical Manufacturing
- Address: 17 Langshan Road, North Zone, High-tech Park, Nanshan District, Shenzhen, Guangdong Province, Joincare Pharmaceutical Group Building
- Website: https://www.joincare.com
- Company Profile: The company was transformed from Shenzhen Taita Pharmaceutical Co., Ltd. In January 1994, it was renamed Shenzhen Taita Health Food Co., Ltd. In January 1995, the registered capital increased from USD 550,000 to RMB 30 million, and it was renamed Shenzhen Taita Pharmaceutical Co., Ltd. On September 16, 1999, it was transformed into a joint stock company.
4. Top 10 Circulating Shareholders
| Rank | Institution Name | Institution Type | Shares Held (W) | Percentage Held (%) |
|---|---|---|---|---|
| 1 | Shenzhen Baiyeyuan Investment Co., Ltd. | General Legal Person | 89565.37 | 48.96 |
| 2 | Hong Xin Hang Limited | General Legal Person | 3592.97 | 1.96 |
| 3 | Hong Kong Securities Clearing Company Ltd. | Northbound Capital | 3420.60 | 1.87 |
| 4 | CSI 500 Exchange Traded Fund | Fund | 1593.81 | 0.87 |
| 5 | Ruizhong Life Insurance Co., Ltd. - Proprietary Funds | Insurance | 1273.92 | 0.70 |
| 6 | Yinhua CSI Innovative Drug Industry ETF | Fund | 1068.29 | 0.58 |
| 7 | Joincare Pharmaceutical Group Industry Co., Ltd. - Medium and Long-term Career Partner Shareholding Plan (Phase 3) | Asset Management Plan | 937.04 | 0.51 |
| 8 | GTJA Allianz Funds - China Pacific Life Insurance Co., Ltd. - Participating Insurance - GTJA Allianz Funds China Pacific Life Insurance Equity Relative Return (Policy Bonus) Single Asset Management Plan | Asset Management Plan | 795.72 | 0.43 |
| 9 | GTJA Allianz Derson Small Cap Selected Securities Investment Fund | Fund | 424.84 | 0.23 |
| 10 | GTJA Allianz Value Selection Mixed Securities Investment Fund | Fund | 53.30 | 0.03 |
5. Concept Sectors
- Guangdong-Hong Kong-Macao Greater Bay Area
- Artificial Intelligence
- Tencent Concept
- GDR Included
- Assisted Reproduction
- Innovative Drugs
- Weight Loss Drugs
- Synthetic Biology
- Pet Economy
- DeepSeek
- AI Healthcare
Remarks
- Data update date: 2025-09-30
- Data source: Public market information